News

Steps towards secure, sustainable and inclusive digitalisation 03-09-2021

 
Digitalisation.jpg

A set of EU digital principles: social security & health insurers’ views

As a follow-up to the Digital Compass Communication of 9 March, the Commission launched a public consultation on the formulation of a set of EU digital principles. These principles would be integrated in a joint declaration of the main EU institutions. ESIP and its Members are committed to and involved in the digitalisation of social security and healthcare systems, with a view to increasing their sustainability and accessibility within and across borders.

Proposals to improve EU rules on rare and paediatric diseases 30-07-2021

 
Rare_Diseases_3_.png

ESIP responds to the Public Consultation on the Revision of the OMP and paediatrics Regulations

As part of the legislative initiatives under the Pharmaceutical Strategy for Europe, the Commission opened consultations towards the revision of the EU legislation on medicines for children and rare diseases. ESIP provided its feedback building on the 2019 paper on orphan medicinal products and the previous response to the inception impact assessment

 

Promoting access to health data for healthcare, research & policy-making 26-07-2021

 
Data_Space__1_.jpg

ESIP responds to the Public Consultation on the upcoming European Health Data Space

In view of the legislative proposal for a European Health Data Space (EHDS), expected by the end of this year, ESIP took part in the public consultation process on access to and exchange of health data for healthcare provision, policy-making and research & innovation purposes, as well as on the use of digital health products & services and development & deployment of AI systems applied to healthcare.

First insight into the revision of the EU pharma legislation 27-04-2021

 
Pharmaceuticals__2_2.jpg

ESIP responds to the evaluation roadmap-inception impact assessment

On 30 March the Commission launched the first stage of consultations with stakeholders towards the revision of the general pharmaceutical legislation, namely Directive 2001/83/EC1 and Regulation (EC) No 726/2004. ESIP submitted its first response to the evaluation roadmap-inception impact assessment touching upon several elements identified by the Commission to feed into future policy actions.